Home > Insider Trading > Filing (0001140361-15-036416)

Filing Details

Accession Number:: 0001140361-15-036416
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-10-01 11:52:32
Reporting Period:: 2015-03-17

Filing Date:: 2015-10-01
Accepted Time:: 2015-10-01 11:52:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082038	Durect Corp	DRRX	Pharmaceutical Preparations (2834)	943297098

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1457518	First Eagle Value In Biotechnology Master Fund, Ltd.	Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205	No	No	Yes	No
1459688	21 April Fund Lp	First Eagle Investment Management, Llc 1345 Avenue Of The Americas, 44Th Floor New York NY 10105	No	No	Yes	No
1459708	Ltd Fund April 21	Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205	No	No	Yes	No
1637141	Arnhold & S. Bleichroeder Holdings, Inc.	1345 Avenue Of The Americas New York NY 10105	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-03-17	67,200	$1.59	13,196,397	No	4	P	Direct
Common Stock	Acquisiton	2015-09-29	885,049	$1.80	14,081,446	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Represents 9,579, 35,221 and 22,400 shares purchased by 21 April Fund, LP ("21 April LP"), 21 April Fund, Ltd. ("21 April Ltd."), and First Eagle Value in Biotechnology Master Fund, Ltd. ("FEVIBM" and, together with 21 April LP and 21 April Ltd., the "Funds"), respectively. First Eagle Management, LLC ("FEIM") is general partner of 21 April LP, the registered investment adviser to the Funds and a subsidiary of Arnhold and S. Bleichroeder Holdings, Inc. ("ASBH"). ASBH disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its percuniary interest therein, and this report shall not be deemed an admission that ASBH is the Section 16 beneficial owner of any such securities.
Represents 1,729,489, 6,379,964 and 5,086,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. ASBH disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that ASBH is the Section 16 beneficial owner of any such securities.
Represents 206,806 and 678,243 shares purchased by 21 April LP and 21 April Ltd., respectively. ASBH disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that ASBH is the Section 16 beneficial owner of any such securities.
Represents 1,936,295, 7,058,207 and 5,086,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. ASBH disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that ASBH is the Section 16 beneficial owner of any such securities.